Results     02-May-22
Announcements
Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
Sales rise 10.57% to Rs 1415.74 crore
Net profit of Alembic Pharmaceuticals declined 85.86% to Rs 35.46 crore in the quarter ended March 2022 as against Rs 250.70 crore during the previous quarter ended March 2021. Sales rose 10.57% to Rs 1415.74 crore in the quarter ended March 2022 as against Rs 1280.39 crore during the previous quarter ended March 2021.

For the full year,net profit declined 53.68% to Rs 545.68 crore in the year ended March 2022 as against Rs 1178.11 crore during the previous year ended March 2021. Sales declined 1.62% to Rs 5305.79 crore in the year ended March 2022 as against Rs 5393.13 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales1415.741280.39 11 5305.795393.13 -2
OPM %11.3125.01 -16.4827.45 -
PBDT163.67343.08 -52 906.891551.55 -42
PBT40.59291.86 -86 620.111368.08 -55
NP35.46250.70 -86 545.681178.11 -54

Previous News
  Alembic Pharmaceuticals consolidated net profit rises 48.01% in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
 ( Hot Pursuit - 28-Sep-24   13:02 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Ribociclib Tablets
 ( Corporate News - 01-Apr-24   11:51 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharmaceuticals receives USFDA approval for various products
 ( Corporate News - 09-May-24   09:01 )
  Volumes spurt at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 08-Jun-23   14:30 )
  Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
 ( Hot Pursuit - 19-Jan-23   14:12 )
  Volumes spurt at One 97 Communications Ltd counter
 ( Hot Pursuit - 08-Jun-23   11:00 )
  Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
 ( Hot Pursuit - 09-Mar-23   09:18 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top